The DOI matches its Crossref record; 128 of the 128 references it cites were found in a registry or an index.
Mitochondria Targeting as an Effective Strategy for Cancer Therapy
Open accessAbstract
Mitochondria are well known for their role in ATP production and biosynthesis of macromolecules. Importantly, increasing experimental evidence points to the roles of mitochondrial bioenergetics, dynamics, and signaling in tumorigenesis. Recent studies have shown that many types of cancer cells, including metastatic tumor cells, therapy-resistant tumor cells, and cancer stem cells, are reliant on mitochondrial respiration, and upregulate oxidative phosphorylation (OXPHOS) activity to fuel tumorigenesis. Mitochondrial metabolism is crucial for tumor proliferation, tumor survival, and metastasis. Mitochondrial OXPHOS dependency of cancer has been shown to underlie the development of resistance to chemotherapy and radiotherapy. Furthermore, recent studies have demonstrated that elevated heme synthesis and uptake leads to intensified mitochondrial respiration and ATP generation, thereby promoting tumorigenic functions in non-small cell lung cancer (NSCLC) cells. Also, lowering heme uptake/synthesis inhibits mitochondrial OXPHOS and effectively reduces oxygen consumption, thereby inhibiting cancer cell proliferation, migration, and tumor growth in NSCLC. Besides metabolic changes, mitochondrial dynamics such as fission and fusion are also altered in cancer cells. These alterations render mitochondria a vulnerable target for cancer therapy. This review summarizes recent advances in the understanding of mitochondrial alterations in cancer cells that contribute to tumorigenesis and the development of drug resistance. It highlights novel approaches involving mitochondria targeting in cancer therapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Xie, Y., Lv, Y., Zhang, Y., Liang, Z., Han, L., & Xie, Y. (2018) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.10.097 · Cited by 46
RetractedHallmarks of Cancer: The Next Generation
Hanahan, D., & Weinberg, R. A. (2011) · Cell · doi:10.1016/j.cell.2011.02.013 · Cited by 66,590
Free radicals, metals and antioxidants in oxidative stress-induced cancer
Valko, M., Rhodes, C. J., Moncol, J., Izakovic, M., & Mazur, M. (2006) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2005.12.009 · Cited by 6,680
IDH1 and IDH2 Mutations in Gliomas
Yan, H., Parsons, D. W., Jin, G., McLendon, R., Rasheed, B. A., Yuan, W., Kos, I., Batinic-Haberle, I., Jones, S., Riggins, G. J., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0808710 · Cited by 5,847
Targeting cancer cells by ROS-mediated mechanisms: a radical therapeutic approach?
Trachootham, D., Alexandre, J., & Huang, P. (2009) · Nature Reviews Drug Discovery · doi:10.1038/nrd2803 · Cited by 5,452
Modulation of oxidative stress as an anticancer strategy
Gorrini, C., Harris, I. S., & Mak, T. W. (2013) · Nature Reviews Drug Discovery · doi:10.1038/nrd4002 · Cited by 3,579
Mitochondrial TCA cycle metabolites control physiology and disease
Martínez-Reyes, I., & Chandel, N. S. (2020) · Nature Communications · doi:10.1038/s41467-019-13668-3 · Cited by 2,813
DeBerardinis, R. J., Mancuso, A., Daikhin, E., Nissim, I., Yudkoff, M., Wehrli, S., & Thompson, C. B. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0709747104 · Cited by 2,622
Oncogene-induced Nrf2 transcription promotes ROS detoxification and tumorigenesis
DeNicola, G. M., Karreth, F. A., Humpton, T. J., Gopinathan, A., Wei, C., Frese, K., Mangal, D., Yu, K. H., Yeo, C. J., Calhoun, E. S., et al. (2011) · Nature · doi:10.1038/nature10189 · Cited by 2,277
Ros and ros-mediated cellular signaling
Zhang, J., Wang, X., Vikash, V., Ye, Q., Wu, D., Liu, Y., & Dong, W. (2016) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2016/4350965 · Cited by 1,980
Vyas, S., Zaganjor, E., & Haigis, M. C. (2016) · Cell · doi:10.1016/j.cell.2016.07.002 · Cited by 1,735
Mitochondrial ROS in cancer: initiators, amplifiers or an Achilles' heel?
Sabharwal, S. S., & Schumacker, P. T. (2014) · Nature Reviews Cancer · doi:10.1038/nrc3803 · Cited by 1,622
Cancer metabolism: a therapeutic perspective
Martinez-Outschoorn, U. E., Peiris-Pagés, M., Pestell, R. G., Sotgia, F., & Lisanti, M. P. (2017) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2016.60 · Cited by 1,505
LeBleu, V. S., O’Connell, J. T., Gonzalez Herrera, K. N., Wikman, H., Pantel, K., Haigis, M. C., de Carvalho, F. M., Damascena, A., Domingos Chinen, L. T., Rocha, R. M., et al. (2014) · Nature Cell Biology · doi:10.1038/ncb3039 · Cited by 1,404
Targeting mitochondria metabolism for cancer therapy
Weinberg, S. E., & Chandel, N. S. (2015) · Nature Chemical Biology · doi:10.1038/nchembio.1712 · Cited by 1,381
Acetyl coenzyme A: a central metabolite and second messenger
Pietrocola, F., Galluzzi, L., Bravo-San Pedro, J. M., Madeo, F., & Kroemer, G. (2015) · Cell Metabolism · doi:10.1016/j.cmet.2015.05.014 · Cited by 1,378
Mitochondrial metabolism and cancer
Porporato, P. E., Filigheddu, N., Pedro, J. M. B.-S., Kroemer, G., & Galluzzi, L. (2018) · Cell Research · doi:10.1038/cr.2017.155 · Cited by 1,273
Targeting Antioxidants to Mitochondria by Conjugation to Lipophilic Cations
Murphy, M. P., & Smith, R. A. J. (2007) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.47.120505.105110 · Cited by 1,173
An inhibitor of mutant IDH1 delays growth and promotes differentiation of glioma cells
Rohle, D., Popovici-Muller, J., Palaskas, N., Turcan, S., Grommes, C., Campos, C., Tsoi, J., Clark, O., Oldrini, B., Komisopoulou, E., et al. (2013) · Science · doi:10.1126/science.1236062 · Cited by 1,153
Metabolic heterogeneity in human lung tumors
Hensley, C. T., Faubert, B., Yuan, Q., Lev-Cohain, N., Jin, E., Kim, J., Jiang, L., Ko, B., Skelton, R., Loudat, L., et al. (2016) · Cell · doi:10.1016/j.cell.2015.12.034 · Cited by 1,138
Oxidative Phosphorylation as an Emerging Target in Cancer Therapy
Ashton, T. M., McKenna, W. G., Kunz-Schughart, L. A., & Higgins, G. S. (2018) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-17-3070 · Cited by 1,135
Metformin inhibits mitochondrial complex I of cancer cells to reduce tumorigenesis
Wheaton, W. W., Weinberg, S. E., Hamanaka, R. B., Soberanes, S., Sullivan, L. B., Anso, E., Glasauer, A., Dufour, E., Mutlu, G. M., Budigner, G. S., et al. (2014) · eLife · doi:10.7554/elife.02242 · Cited by 1,105
Glucose-Independent Glutamine Metabolism via TCA Cycling for Proliferation and Survival in B Cells
Le, A., Lane, A. N., Hamaker, M., Bose, S., Gouw, A., Barbi, J., Tsukamoto, T., Rojas, C. J., Slusher, B. S., Zhang, H., et al. (2012) · Cell Metabolism · doi:10.1016/j.cmet.2011.12.009 · Cited by 1,095
Energy metabolism in tumor cells
Moreno‐Sánchez, R., Rodríguez‐Enríquez, S., Marín‐Hernández, A., & Saavedra, E. (2007) · The FEBS Journal · doi:10.1111/j.1742-4658.2007.05686.x · Cited by 1,082
Antitumor activity of the glutaminase inhibitor CB-839 in triple-negative breast cancer
Gross, M. I., Demo, S. D., Dennison, J. B., Chen, L., Chernov-Rogan, T., Goyal, B., Janes, J. R., Laidig, G. J., Lewis, E. R., Li, J., et al. (2014) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-13-0870 · Cited by 1,068
Targeting Metabolism for Cancer Therapy
Luengo, A., Gui, D. Y., & Vander Heiden, M. G. (2017) · Cell Chemical Biology · doi:10.1016/j.chembiol.2017.08.028 · Cited by 971
Farge, T., Saland, E., de Toni, F., Aroua, N., Hosseini, M., Perry, R., Bosc, C., Sugita, M., Stuani, L., Fraisse, M., et al. (2017) · Cancer Discovery · doi:10.1158/2159-8290.cd-16-0441 · Cited by 912
Oncogenic BRAF Regulates Oxidative Metabolism via PGC1α and MITF
Haq, R., Shoag, J., Andreu-Perez, P., Yokoyama, S., Edelman, H., Rowe, G. C., Frederick, D. T., Hurley, A. D., Nellore, A., Kung, A. L., et al. (2013) · Cancer Cell · doi:10.1016/j.ccr.2013.02.003 · Cited by 818
Mitochondrial dynamics regulates migration and invasion of breast cancer cells
Zhao, J., Zhang, J., Yu, M., Xie, Y., Huang, Y., Wolff, D. W., Abel, P. W., & Tu, Y. (2013) · Oncogene · doi:10.1038/onc.2012.494 · Cited by 759
Environment impacts the metabolic dependencies of Ras-driven non-small cell lung cancer
Davidson, S. M., Papagiannakopoulos, T., Olenchock, B. A., Heyman, J. E., Keibler, M. A., Luengo, A., Bauer, M. R., Jha, A. K., O’Brien, J. P., Pierce, K. A., et al. (2016) · Cell Metabolism · doi:10.1016/j.cmet.2016.01.007 · Cited by 737
Effects of metformin and other biguanides on oxidative phosphorylation in mitochondria
Bridges, H. R., Jones, A. J. Y., Pollak, M. N., & Hirst, J. (2014) · Biochemical Journal · doi:10.1042/bj20140620 · Cited by 661
Lee, K.-M., Giltnane, J. M., Balko, J. M., Schwarz, L. J., Guerrero-Zotano, A. L., Hutchinson, K. E., Nixon, M. J., Estrada, M. V., Sánchez, V., Sanders, M. E., et al. (2017) · Cell Metabolism · doi:10.1016/j.cmet.2017.09.009 · Cited by 650
The metabolic profile of tumors depends on both the responsible genetic lesion and tissue type
Yuneva, M. O., Fan, T. W. M., Allen, T. D., Higashi, R. M., Ferraris, D. V., Tsukamoto, T., Matés, J. M., Alonso, F. J., Wang, C., Seo, Y., et al. (2012) · Cell Metabolism · doi:10.1016/j.cmet.2011.12.015 · Cited by 639
Metformin, independent of AMPK, induces mTOR inhibition and cell-cycle arrest through REDD1
Ben Sahra, I., Regazzetti, C., Robert, G., Laurent, K., Le Marchand-Brustel, Y., Auberger, P., Tanti, J.-F., Giorgetti-Peraldi, S., & Bost, F. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-1769 · Cited by 616
Inhibition of mitochondrial fission prevents cell cycle progression in lung cancer
Rehman, J., Zhang, H. J., Toth, P. T., Zhang, Y., Marsboom, G., Hong, Z., Salgia, R., Husain, A. N., Wietholt, C., & Archer, S. L. (2012) · The FASEB Journal · doi:10.1096/fj.11-196543 · Cited by 595
Chapter 4: Estrogens as Endogenous Genotoxic Agents--DNA Adducts and Mutations
Cavalieri, E., Frenkel, K., Liehr, J. G., Rogan, E., & Roy, D. (2000) · JNCI Monographs · doi:10.1093/oxfordjournals.jncimonographs.a024247 · Cited by 595
ASCT2/SLC1A5 controls glutamine uptake and tumour growth in triple-negative basal-like breast cancer
van Geldermalsen, M., Wang, Q., Nagarajah, R., Marshall, A. D., Thoeng, A., Gao, D., Ritchie, W., Feng, Y., Bailey, C. G., Deng, N., et al. (2016) · Oncogene · doi:10.1038/onc.2015.381 · Cited by 580
The emerging role and targetability of the TCA cycle in cancer metabolism
Anderson, N. M., Mucka, P., Kern, J. G., & Feng, H. (2018) · Protein & Cell · doi:10.1007/s13238-017-0451-1 · Cited by 556
Kuntz, E. M., Baquero, P., Michie, A. M., Dunn, K., Tardito, S., Holyoake, T. L., Helgason, G. V., & Gottlieb, E. (2017) · Nature Medicine · doi:10.1038/nm.4399 · Cited by 546
IDH mutations in cancer and progress toward development of targeted therapeutics
Dang, L., Yen, K., & Attar, E. C. (2016) · Annals of Oncology · doi:10.1093/annonc/mdw013 · Cited by 509
A Prospective Study of Red and Processed Meat Intake in Relation to Cancer Risk
Cross, A. J., Leitzmann, M. F., Gail, M. H., Hollenbeck, A. R., Schatzkin, A., & Sinha, R. (2007) · PLoS Medicine · doi:10.1371/journal.pmed.0040325 · Cited by 476
AG-221, a First-in-Class Therapy Targeting Acute Myeloid Leukemia Harboring Oncogenic IDH2 Mutations
Yen, K., Travins, J., Wang, F., David, M. D., Artin, E., Straley, K., Padyana, A., Gross, S., DeLaBarre, B., Tobin, E., et al. (2017) · Cancer Discovery · doi:10.1158/2159-8290.cd-16-1034 · Cited by 471
Small-Molecule MYC Inhibitors Suppress Tumor Growth and Enhance Immunotherapy
Han, H., Jain, A. D., Truica, M. I., Izquierdo-Ferrer, J., Anker, J. F., Lysy, B., Sagar, V., Luan, Y., Chalmers, Z. R., Unno, K., et al. (2019) · Cancer Cell · doi:10.1016/j.ccell.2019.10.001 · Cited by 465
Metformin directly acts on mitochondria to alter cellular bioenergetics
Andrzejewski, S., Gravel, S.-P., Pollak, M., & St-Pierre, J. (2014) · Cancer & Metabolism · doi:10.1186/2049-3002-2-12 · Cited by 430
Targeted inhibition of tumor-specific glutaminase diminishes cell-autonomous tumorigenesis
Xiang, Y., Stine, Z. E., Xia, J., Lu, Y., O’Connor, R. S., Altman, B. J., Hsieh, A. L., Gouw, A. M., Thomas, A. G., Gao, P., et al. (2015) · Journal of Clinical Investigation · doi:10.1172/jci75836 · Cited by 409
Howell, J. J., Hellberg, K., Turner, M., Talbott, G., Kolar, M. J., Ross, D. S., Hoxhaj, G., Saghatelian, A., Shaw, R. J., & Manning, B. D. (2017) · Cell Metabolism · doi:10.1016/j.cmet.2016.12.009 · Cited by 408
ATP citrate lyase: activation and therapeutic implications in non-small cell lung cancer
Migita, T., Narita, T., Nomura, K., Miyagi, E., Inazuka, F., Matsuura, M., Ushijima, M., Mashima, T., Seimiya, H., Satoh, Y., et al. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-1235 · Cited by 403
A role for mitochondrial enzymes in inherited neoplasia and beyond
Eng, C., Kiuru, M., Fernandez, M. J., & Aaltonen, L. A. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1013 · Cited by 392
Leboucher, G. P., Tsai, Y. C., Yang, M., Shaw, K. C., Zhou, M., Veenstra, T. D., Glickman, M. H., & Weissman, A. M. (2012) · Molecular Cell · doi:10.1016/j.molcel.2012.05.041 · Cited by 334
HIF Inhibitors: Status of Current Clinical Development
Fallah, J., & Rini, B. I. (2019) · Current Oncology Reports · doi:10.1007/s11912-019-0752-z · Cited by 308
Mense, S. M., & Zhang, L. (2006) · Cell Research · doi:10.1038/sj.cr.7310086 · Cited by 305
Self-citationThe role of oxidative stress on breast cancer development and therapy
Hecht, F., Pessoa, C. F., Gentile, L. B., Rosenthal, D., Carvalho, D. P., & Fortunato, R. S. (2016) · Tumor Biology · doi:10.1007/s13277-016-4873-9 · Cited by 303
Regulators of mitochondrial dynamics in cancer
Senft, D., & Ronai, Z. A. (2016) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2016.02.001 · Cited by 297
Mitochondrial complex ii: At the crossroads
Bezawork-Geleta, A., Rohlena, J., Dong, L., Pacak, K., & Neuzil, J. (2017) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2017.01.003 · Cited by 295 · cited 1×
“During metabolic processes, electrons released from the mitochondrial ETC are captured by molecular oxygen to generate superoxide anions, which leads to the production of ROS [37,39,40].”
BackgroundTargeting mitochondrial biogenesis to overcome drug resistance to MAPK inhibitors
Zhang, G., Frederick, D. T., Wu, L., Wei, Z., Krepler, C., Srinivasan, S., Chae, Y. C., Xu, X., Choi, H., Dimwamwa, E., et al. (2016) · Journal of Clinical Investigation · doi:10.1172/jci82661 · Cited by 286
Red meat and colon cancer: the cytotoxic and hyperproliferative effects of dietary heme.
Sesink, A. L. A., Termont, D. S., KLEIBEUKER, J. H., & van der Meer, R. (1999) · PubMed · Cited by 274
Tumors and Mitochondrial Respiration: A Neglected Connection
Viale, A., Corti, D., & Draetta, G. F. (2015) · Cancer Research · doi:10.1158/0008-5472.can-15-0491 · Cited by 266
Janzer, A., German, N. J., Gonzalez-Herrera, K. N., Asara, J. M., Haigis, M. C., & Struhl, K. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1409844111 · Cited by 265
Cytoprotective roles for autophagy
Moreau, K., Luo, S., & Rubinsztein, D. C. (2010) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2009.12.002 · Cited by 264
GUPPY, M., LEEDMAN, P., ZU, X., & RUSSELL, V. (2002) · Biochemical Journal · doi:10.1042/bj3640309 · Cited by 251
Mitophagy in Cancer: A Tale of Adaptation
Vara-Perez, M., Felipe-Abrio, B., & Agostinis, P. (2019) · Cells · doi:10.3390/cells8050493 · Cited by 251
Martinez-Outschoorn, U. E., Pavlides, S., Howell, A., Pestell, R. G., Tanowitz, H. B., Sotgia, F., & Lisanti, M. P. (2011) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2011.01.023 · Cited by 248
Metformin Targets Central Carbon Metabolism and Reveals Mitochondrial Requirements in Human Cancers
Liu, X., Romero, I. L., Litchfield, L. M., Lengyel, E., & Locasale, J. W. (2016) · Cell Metabolism · doi:10.1016/j.cmet.2016.09.005 · Cited by 236
Mitochondrial Localization and the Persistent Migration of Epithelial Cancer cells
Desai, S. P., Bhatia, S. N., Toner, M., & Irimia, D. (2013) · Biophysical Journal · doi:10.1016/j.bpj.2013.03.025 · Cited by 223
HO-1 Induction in Cancer Progression: A Matter of Cell Adaptation
Nitti, M., Piras, S., Marinari, U., Moretta, L., Pronzato, M., & Furfaro, A. (2017) · Antioxidants · doi:10.3390/antiox6020029 · Cited by 223
Targeting SOD1 reduces experimental non–small-cell lung cancer
Glasauer, A., Sena, L. A., Diebold, L. P., Mazar, A. P., & Chandel, N. S. (2014) · Journal of Clinical Investigation · doi:10.1172/jci71714 · Cited by 212
Oncogenic potential of Nrf2 and its principal target protein heme oxygenase-1
Na, H.-K., & Surh, Y.-J. (2014) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2013.10.819 · Cited by 202
New therapeutic strategies to treat human cancers expressing mutant p53 proteins
Blandino, G., & Di Agostino, S. (2018) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-018-0705-7 · Cited by 201
Qian, W., Choi, S., Gibson, G. A., Watkins, S. C., Bakkenist, C. J., & Van Houten, B. (2012) · Journal of Cell Science · doi:10.1242/jcs.109769 · Cited by 200
Meat Consumption and Risk of Esophageal and Gastric Cancer in a Large Prospective Study
Cross, A. J., Freedman, N. D., Ren, J., Ward, M. H., Hollenbeck, A. R., Schatzkin, A., Sinha, R., & Abnet, C. C. (2011) · American Journal of Gastroenterology · doi:10.1038/ajg.2010.415 · Cited by 197
Hooda, J., Shah, A., & Zhang, L. (2014) · Nutrients · doi:10.3390/nu6031080 · Cited by 193
Self-citationTargeting Glutamine Metabolism in Breast Cancer with Aminooxyacetate
Korangath, P., Teo, W. W., Sadik, H., Han, L., Mori, N., Huijts, C. M., Wildes, F., Bharti, S., Zhang, Z., Santa-Maria, C. A., et al. (2015) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-14-1200 · Cited by 182
Mitochondrial dynamics and cancer
Grandemange, S., Herzig, S., & Martinou, J.-C. (2009) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2008.12.001 · Cited by 181
Glucose Metabolism Heterogeneity in Human and Mouse Malignant Glioma Cell Lines
Griguer, C. E., Oliva, C. R., & Gillespie, G. Y. (2005) · Journal of Neuro-Oncology · doi:10.1007/s11060-004-6404-6 · Cited by 178
Xin, M., Qiao, Z., Li, J., Liu, J., Song, S., Zhao, X., Miao, P., Tang, T., Wang, L., Liu, W., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.10020 · Cited by 177
Bolzoni, M., Chiu, M., Accardi, F., Vescovini, R., Airoldi, I., Storti, P., Todoerti, K., Agnelli, L., Missale, G., Andreoli, R., et al. (2016) · Blood · doi:10.1182/blood-2016-01-690743 · Cited by 176
Mitochondrial fusion exploits a therapeutic vulnerability of pancreatic cancer
Yu, M., Nguyen, N. D., Huang, Y., Lin, D., Fujimoto, T. N., Molkentine, J. M., Deorukhkar, A., Kang, Y., San Lucas, F. A., Fernandes, C. J., et al. (2019) · JCI Insight · doi:10.1172/jci.insight.126915 · Cited by 173
Haem as a multifunctional regulator
Padmanaban, G., Venkateswar, V., & Rangarajan, P. N. (1989) · Trends in Biochemical Sciences · doi:10.1016/0968-0004(89)90182-5 · Cited by 168
Glutaminase: A Hot Spot For Regulation Of Cancer Cell Metabolism?
Erickson, J. W., & Cerione, R. A. (2010) · Oncotarget · doi:10.18632/oncotarget.208 · Cited by 158
Metabolism-Based Therapeutic Strategies Targeting Cancer Stem Cells
Jagušt, P., de Luxán‐Delgado, B., Parejo-Alonso, B., & Sancho, P. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.00203 · Cited by 153
Involvement of Drp1 in hypoxia-induced migration of human glioblastoma U251 cells
Wan, Y., Zhang, J., Yang, Z., Jiang, L., WEI, Y.-F., Lai, Q., WANG, J.-B., XIN, H.-B., & Han, X. (2014) · Oncology Reports · doi:10.3892/or.2014.3235 · Cited by 152
Wang, M., Wu, H., Fu, G., Zhang, H., Zhou, X., Tang, L., Dong, L., Qin, C., Huang, S., Zhao, L., et al. (2015) · Hepatology · doi:10.1002/hep.28415 · Cited by 152
Mitochondria and the hallmarks of cancer
Giampazolias, E., & Tait, S. W. G. (2015) · FEBS Journal · doi:10.1111/febs.13603 · Cited by 151
Metabolic shift toward oxidative phosphorylation in docetaxel resistant prostate cancer cells
Ippolito, L., Marini, A., Cavallini, L., Morandi, A., Pietrovito, L., Pintus, G., Giannoni, E., Schrader, T. H., Puhr, M., Chiarugi, P., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.11301 · Cited by 149
Rohlenová, K., Sachaphibulkij, K., Štursa, J., Bezawork‐Geleta, A., Blecha, J., Endaya, B., Werner, L., Černý, J., Zobalová, R., Goodwin, J., et al. (2016) · Antioxidants and Redox Signaling · doi:10.1089/ars.2016.6677 · Cited by 143
Dysregulation of mitochondrial dynamics proteins are a targetable feature of human tumors
Anderson, G. R., Wardell, S. E., Çakır, M., Yip, C., Ahn, Y.-R., Ali, M., Yllanes, A. P., Chao, C., McDonnell, D. P., & Wood, K. C. (2018) · Nature Communications · doi:10.1038/s41467-018-04033-x · Cited by 138
Hirpara, J. L., Eu, J. Q., Tan, J. K. M., Wong, A. L., Clement, M., Kong, L. R., Ohi, N., Tsunoda, T., Qu, J., Goh, B. C., et al. (2018) · Redox Biology · doi:10.1016/j.redox.2018.101076 · Cited by 133
The Multifaceted Role of Heme in Cancer
Fiorito, V., Chiabrando, D., Petrillo, S., Bertino, F., & Tolosano, E. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2019.01540 · Cited by 129
Enhanced Heme Function and Mitochondrial Respiration Promote the Progression of Lung Cancer Cells
Hooda, J., Cadinu, D., Alam, M. M., Shah, A. N., Cao, T., Sullivan, L. A., Brekken, R. A., & Li, Z. (2013) · PLoS ONE · doi:10.1371/journal.pone.0063402 · Cited by 127
Oxidative Phosphorylation: A Target for Novel Therapeutic Strategies Against Ovarian Cancer
Nayak, A., Kapur, A., Barroilhet, L., & Patankar, M. S. (2018) · Cancers · doi:10.3390/cancers10090337 · Cited by 127
Mitochondrial dynamics and cancer
Maycotte, P., Marín‐Hernández, Á., Goyri-Aguirre, M., Anaya-Ruíz, M., Reyes‐Leyva, J., & Cortés-Hernández, P. (2017) · Tumor Biology · doi:10.1177/1010428317698391 · Cited by 125
Peiris‐Pagès, M., Bonuccelli, G., Sotgia, F., & Lisanti, M. P. (2018) · Oncotarget · doi:10.18632/oncotarget.24285 · Cited by 124
Targeting mitochondria as an anticancer strategy
Dong, L., & Neužil, J. (2019) · 癌症:英文版 · doi:10.1186/s40880-019-0412-6 · Cited by 117
Zhan, L., Cao, H., Wang, G., Lyu, Y., Sun, X., An, J., Wu, Z., Huang, Q., Liu, B.-R., & Xing, J. (2016) · Oncotarget · doi:10.18632/oncotarget.11339 · Cited by 114
TCA Cycle Rewiring as Emerging Metabolic Signature of Hepatocellular Carcinoma
Todisco, S., Convertini, P., Iacobazzi, V., & Infantino, V. (2019) · Cancers · doi:10.3390/cancers12010068 · Cited by 112
The mitochondrial dynamics in cancer and immune-surveillance
Simula, L., Nazio, F., & Campello, S. (2017) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2017.06.007 · Cited by 111
Non‐muscle myosins in tumor progression, cancer cell invasion, and metastasis
Ouderkirk, J. L., & Krendel, M. (2014) · Cytoskeleton · doi:10.1002/cm.21187 · Cited by 110
Dong, L., Jameson, V. J. A., Tilly, D., Procházka, L., Rohlena, J., Vališ, K., Truksa, J., Zobalová, R., Mahdavian, E., Kľučková, K., et al. (2011) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2011.02.032 · Cited by 106
Glutamine Addiction In Gliomas
Márquez, J., Alonso, F. J., Matés, J. M., Segura, J. A., Martín‐Rufián, M., & Campos-Sandoval, J. A. (2017) · Neurochemical Research · doi:10.1007/s11064-017-2212-1 · Cited by 106
Mitohormesis Primes Tumor Invasion and Metastasis
Kenny, T. C., Craig, A. J., Villanueva, A., & Germain, D. (2019) · Cell Reports · doi:10.1016/j.celrep.2019.04.095 · Cited by 102
Sohoni, S. S., Ghosh, P., Wang, T., Kalainayakan, S. P., Vidal, C., Dey, S., Konduri, P. C., & Li, Z. (2019) · Cancer Research · doi:10.1158/0008-5472.can-18-2156 · Cited by 95
Self-citationRole of mitochondrial function in the invasiveness of human colon cancer cells
Lin, C., Liu, L.-T., Ou, L.-H., Pan, S.-C., Lin, C.-I., & Wei, Y. (2017) · Oncology Reports · doi:10.3892/or.2017.6087 · Cited by 82
Liu, D., Angelova, A., Liu, J., Garamus, V. M., Angelov, B., Zhang, X., Li, Y., Feger, G., Li, N., & Zou, A. (2019) · Journal of Materials Chemistry B · doi:10.1039/c9tb00629j · Cited by 82
ATP citrate lyase is increased in human breast cancer, depletion of which promotes apoptosis
Wang, D., Yin, L., Wei, J., Yang, Z.-X., & Jiang, G. (2017) · Tumor Biology · doi:10.1177/1010428317698338 · Cited by 78
Tanwar, D. K., Parker, D. J., Gupta, P., Spurlock, B., Alvarez, R. D., Basu, M. K., & Mitra, K. (2016) · Oncotarget · doi:10.18632/oncotarget.11047 · Cited by 77
Liu, L., Qi, L., Knifley, T., Piecoro, D. W., Rychahou, P. G., Liu, J., Mitov, M. I., Martin, J. T., Wang, C., Wu, J., et al. (2019) · Journal of Biological Chemistry · doi:10.1074/jbc.ra118.004365 · Cited by 75
Pan, L., Zhou, L., Yin, W., Bai, J. Q. A., & Liu, R. (2018) · International Journal of Oncology · doi:10.3892/ijo.2018.4380 · Cited by 70
Myosins as fundamental components during tumorigenesis: diverse and indispensable
Li, Y.-R., & Yang, W. (2016) · Oncotarget · doi:10.18632/oncotarget.8800 · Cited by 65
Essential roles of mitochondrial and heme function in lung cancer bioenergetics and tumorigenesis
Kalainayakan, S. P., FitzGerald, K. E., Konduri, P. C., Vidal, C., & Li, Z. (2018) · Cell & Bioscience · doi:10.1186/s13578-018-0257-8 · Cited by 63
Self-citationGlutamine antagonists in chemotherapy
Livingston, R. B., Venditti, J. M., Cooney, D. A., & Carter, S. K. (1971) · Advances in Pharmacology · doi:10.1016/s1054-3589(08)60594-3 · Cited by 60
Pierre, F. H. F., Santarelli, R. L., Allam, O., Taché, S., Naud, N., Guéraud, F., & Corpet, D. E. (2010) · Nutrition and Cancer · doi:10.1080/01635580903532408 · Cited by 56
Adenine Nucleotide Translocator Transports Haem Precursors into Mitochondria
Azuma, M., Kabe, Y., Kuramori, C., Kondo, M., Yamaguchi, Y., & Handa, H. (2008) · PLoS ONE · doi:10.1371/journal.pone.0003070 · Cited by 54
Kumar, R., Lovell, S., Matsumura, H., Battaile, K. P., Moënne‐Loccoz, P., & Rivera, M. (2013) · Biochemistry · doi:10.1021/bi400280z · Cited by 50
Acivicin: a new glutamine antagonist in clinical trials.
O'Dwyer, P. J., Alonso, M. T., & Leyland-Jones, B. R. (1984) · Journal of Clinical Oncology · doi:10.1200/jco.1984.2.9.1064 · Cited by 49
Mahalingaiah, P. K. S., Ponnusamy, L., & Singh, K. P. (2015) · Breast Cancer Research and Treatment · doi:10.1007/s10549-015-3514-0 · Cited by 47
Alam, M. M., Sohoni, S. S., Kalainayakan, S. P., Garrossian, M., & Li, Z. (2016) · BMC Cancer · doi:10.1186/s12885-016-2200-x · Cited by 45
Role of the host stroma in cancer and its therapeutic significance
Jackson, D. G. (2013) · Cancer and Metastasis Reviews · doi:10.1007/s10555-013-9438-4 · Cited by 43
Huang, Q., Chen, Z., Cheng, P., Zhou, J., Wang, Z., Huang, Y., Yang, C., Pan, J., Qiu, F., & Huang, J. (2019) · Cancer Letters · doi:10.1016/j.canlet.2019.04.021 · Cited by 42
Lukat-Rodgers, G. S., Rodgers, K. R., Caillet‐Saguy, C., Izadi‐Pruneyre, N., & Lecroisey, A. (2008) · Biochemistry · doi:10.1021/bi7019518 · Cited by 41
Lipid Synthesis Is a Metabolic Liability of Non–Small Cell Lung CancerPreprint
Svensson, R. U., & Shaw, R. J. (2016) · Cold Spring Harbor Symposia on Quantitative Biology · doi:10.1101/sqb.2016.81.030874 · Cited by 40
Dekker, L. J. M., Wu, S., Jurriëns, C., Mustafa, D. A. M., Grevers, F., Burgers, P. C., Smitt, P. A. E. S., Kros, J. M., & Luider, T. M. (2020) · The FASEB Journal · doi:10.1096/fj.201902352r · Cited by 40
Tasevska, N., Cross, A. J., Dodd, K. W., Ziegler, R. G., Caporaso, N. E., & Sinha, R. R. (2010) · International Journal of Cancer · doi:10.1002/ijc.25327 · Cited by 39
Altered mitochondrial trafficking as a novel mechanism of cancer metastasis
Furnish, M., & Caino, M. C. (2019) · Cancer Reports · doi:10.1002/cnr2.1157 · Cited by 39
Katt, W. P., Antonyak, M. A., & Cerione, R. A. (2014) · Molecular Pharmaceutics · doi:10.1021/mp500405h · Cited by 33
Wang, H., Luo, J., Tian, W., Yan, W., Ge, S., Zhang, Y., & Sun, W. (2019) · Toxicology · doi:10.1016/j.tox.2019.01.018 · Cited by 31
Kalainayakan, S. P., Ghosh, P., Dey, S., FitzGerald, K. E., Sohoni, S. S., Konduri, P. C., Garrossian, M., Liu, L., & Li, Z. (2019) · Scientific Reports · doi:10.1038/s41598-018-38345-1 · Cited by 23
Self-citationÓzsvári, B., Sotgia, F., & Lisanti, M. P. (2017) · Aging · doi:10.18632/aging.101304 · Cited by 21
Quivoron, C., David, M., Straley, K., Travins, J., Kim, H., Chen, Y., Zhu, D., Saada, V., Bawa, O., Opolon, P., et al. (2014) · Blood · doi:10.1182/blood.v124.21.3735.3735 · Cited by 19
Cited by
Tong, X., Tang, R., Xiao, M., Xu, J., Wang, W., Zhang, B., Liu, J., Yu, X., & Shi, S. (2022) · Journal of Hematology & Oncology · doi:10.1186/s13045-022-01392-3 · Cited by 883
Elesclomol: a copper ionophore targeting mitochondrial metabolism for cancer therapy
Zheng, P., Zhou, C., Lu, L., Liu, B., & Ding, Y. (2022) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-022-02485-0 · Cited by 352
Metadata
- Authors
- Ghosh, P., Vidal, C., Dey, S., & Zhang, L.
- Venue
- International Journal of Molecular Sciences
- Publisher
- MDPI AG
- Published
- 2020-05-09
- Volume
- 21
- Issue
- 9
- Pages
- 3363
- ISSN
- 1422-0067 (ISSN-L)
- OpenAlex
- W3023426209
- Cited by
- 263
- References
- 128
- FWCI
- 8.63
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.